Español
Información por segmentos
Resumen de la empresaALLERGAN PLC
Cada combinación de dimensiones se mantiene separada. Los ingresos y el resultado operativo se muestran tal como se declararon, con sus fechas y fuentes.
Ingresos · Datos de segmentos declarados
Los recuentos incluyen solo filas dimensionales conservadas. Los periodos y miembros pueden cambiar entre informes; no se infieren valores ausentes ni totales esperados.
Operating Segments · International
Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 691400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 835100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 2484300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 1649200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 2634500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Operating Segments · International · Asia Pacific Middle East And Africa
Consolidation Items · Statement Business Segments · Statement Geographical
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:StatementGeographicalAxis=agn:AsiaPacificMiddleEastAndAfricaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1075100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1089900000 | USD | 20200218 | Abrir documento fuente |
Operating Segments · International · Latin America And Canada
Consolidation Items · Statement Business Segments · Statement Geographical
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:StatementGeographicalAxis=agn:LatinAmericaAndCanadaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 772900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 862400000 | USD | 20200218 | Abrir documento fuente |
Operating Segments · International · Other Geographic Area
Consolidation Items · Statement Business Segments · Statement Geographical
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:StatementGeographicalAxis=agn:OtherGeographicAreaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 82300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 69800000 | USD | 20200218 | Abrir documento fuente |
Operating Segments · International · Europe
Consolidation Items · Statement Business Segments · Statement Geographical
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:StatementGeographicalAxis=srt:EuropeMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1471700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1482600000 | USD | 20200218 | Abrir documento fuente |
Operating Segments · US General Medicine
Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1320500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 1518600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 4224200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 2705600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 3925000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Operating Segments · US Specialized Therapeutics
Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1541500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 1670800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 4998800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 3328000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5111500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Aczone · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AczoneMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Aczone · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AczoneMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 3000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 3400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 6800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 55100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 54500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Alloderm · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AllodermMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 2100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 5900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 8000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Alloderm · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AllodermMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 102100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 95000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 291200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 407300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 312400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Alphagan And Combigan · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 36900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 40400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 118900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 176000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 129300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Alphagan And Combigan · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 81600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 90900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 265500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 375400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 277700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Armour Thyroid · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ArmourThyroidMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 46300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 54400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 161100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 198800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 145400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Avycaz · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:AvycazMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 11800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 29600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 86000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 94600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 70000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Botox · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BotoxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 203700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 259500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 775400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1031600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 777100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Botox · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BotoxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 608500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 669200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 1995700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2545800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1854400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Breast Implants · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BreastImplantsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 5200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 5700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | -14500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 130100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 119600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Breast Implants · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BreastImplantsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 40100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 58500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 187300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 263000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 194800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Bystolic And Byvalson · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 1500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Bystolic And Byvalson · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 129800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 152200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 431000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 583800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 432100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Canasa And Salofalk · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 4000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 4400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 12100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 17600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 13100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Canasa And Salofalk · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 7200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 5800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 24000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 169200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 130400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Carafate And Sulcrate · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 2100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 2100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Carafate And Sulcrate · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 19000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 55100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 165600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 217800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 163700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Coolsculpting Consumables · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 8800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 21600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 59700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 64200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 40800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Coolsculpting Consumables · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 22700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 40400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 148900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 235300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 180800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Coolsculpting Systems And Add On Applicators · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 11400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 33600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 43300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 21800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Coolsculpting Systems And Add On Applicators · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 36200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 12600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 45900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 126300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 99500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Dalvance · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:DalvanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 3100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 1400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 3600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Dalvance · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:DalvanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 23000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 23200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 55500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 56100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 38800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Delzicol And Asacol HD · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 7700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 7200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 27200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 45700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 35000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Delzicol And Asacol HD · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 2600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 11900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 68200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 130800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 102900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Eye Drops · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:EyeDropsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 50900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 63800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 176500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 279700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 208000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Eye Drops · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:EyeDropsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 66500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 62000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 169200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 202700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 154800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Juvederm Collection · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:JuvedermCollectionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 113100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 144700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 475200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 614800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 440800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Juvederm Collection · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:JuvedermCollectionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 107500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 134800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 421100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 548200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 389800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Kybella And Belkyra · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 2500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 6300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Kybella And Belkyra · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 5300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 5300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 21100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 31800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 24600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Liletta · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LilettaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 23100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 19900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 56600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 50900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 36300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Linzess And Constella · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 7100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 6700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 17000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 24100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 17700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Linzess And Constella · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 172200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 214700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 572000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 761100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 555900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Lo Loestrin Fe · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LoLoestrinFeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 109800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 161400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 432700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 527700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 383900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Lumigan And Ganfort · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 80700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 89700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 265200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 392600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 295700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Lumigan And Ganfort · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 63000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 67500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 187300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 291800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 217800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Namenda · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:NamendaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 2900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 4000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 19600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 71000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 60300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Namzaric · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:NamzaricMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 17800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 22400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 68400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 115800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 93200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Other · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 80700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 89900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 257100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 380200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 291100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Other · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 188600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 203100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 591000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 749300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 568200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Other · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 56600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 69400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 200600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 308900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 235300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Ozurdex · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:OzurdexMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 63800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 63800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 207900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 187700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 158100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Ozurdex · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:OzurdexMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 29900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 33700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 93900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 111000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 81700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Rapaflo · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:RapafloMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 1500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 3500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 6400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 4600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Rapaflo · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:RapafloMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 5200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 21500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 81900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 63000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Restasis · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:RestasisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 11300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 9200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 31500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 64500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 47900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Restasis · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:RestasisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 278600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 286800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 829400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1197000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 872000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Saphris · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:SaphrisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 31000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 34500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 99000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 139700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 102900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Savella · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:SavellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 19300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 24000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 67000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 85000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 61400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Skin Care · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:SkinCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 2800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 4000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 10400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 15200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 11600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Skin Care · Operating Segments · US Specialized Therapeutics
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:SkinCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 38500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 36100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 113400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 138800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 98400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Teflaro · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:TeflaroMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 1500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 2100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 2300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Teflaro · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:TeflaroMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 35000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 38400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 108900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 128000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 98000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Ubrelvy · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:UbrelvyMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 11100000 | USD | 20200507 | Abrir documento fuente |
Viberzi · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ViberziMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 1200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Viberzi · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ViberziMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 37300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 50100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 138100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 176500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 127600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Viibryd Fetzima · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 3500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 3000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 7800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 7200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 4900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Viibryd Fetzima · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 89800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 105100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 297900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 342400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 246900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Vraylar · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:VraylarMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 277300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 234600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 574400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 487100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 336600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Zenpep · Operating Segments · International
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ZenpepMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 400000 | USD | 20200218 | Abrir documento fuente |
Zenpep · Operating Segments · US General Medicine
Product Or Service · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:ProductOrServiceAxis=agn:ZenpepMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 65600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 74200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 207200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 237300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 170500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Asia Pacific Middle East And Africa · Operating Segments · International
Statement Geographical · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:StatementGeographicalAxis=agn:AsiaPacificMiddleEastAndAfricaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 182800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 266900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 779100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 261500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 512200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 250700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 272400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 796800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Latin America And Canada · Operating Segments · International
Statement Geographical · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:StatementGeographicalAxis=agn:LatinAmericaAndCanadaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 161800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 199900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 560200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 182100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 360300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 178200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 203300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 646200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Other Geographic Area · Operating Segments · International
Statement Geographical · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:StatementGeographicalAxis=agn:OtherGeographicAreaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 23800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 21800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 57900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 17900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 36100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 18200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 16100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 50000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
Europe · Operating Segments · International
Statement Geographical · Consolidation Items · Statement Business Segments
Dimensiones de origen
srt:StatementGeographicalAxis=srt:EuropeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2020 – 31 mar 2020 | 323000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2019 – 30 sept 2019 | 346500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 sept 2019 | 1087100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 386200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 740600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 354400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 329800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1141500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
International · Operating Segments
Statement Business Segments · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 3402000000 | USD | 20200218 | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 847700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 801500000 | USD | 20200507 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 3504700000 | USD | 20200218 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 821600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
International · Operating Segments · Aczone
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AczoneMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 400000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Alloderm
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AllodermMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 7900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 8000000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Alphagan And Combigan
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 162000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 176000000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Botox
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BotoxMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1060800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1031600000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Breast Implants
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BreastImplantsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 130100000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Bystolic And Byvalson
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 2100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2000000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Canasa And Salofalk
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 16800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 17600000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Carafate And Sulcrate
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 3000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2800000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Coolsculpting Consumables
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 76300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 64200000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Coolsculpting Systems And Add On Applicators
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 42400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 43300000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Dalvance
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:DalvanceMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 6000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2300000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Delzicol And Asacol HD
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 36100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 45700000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Eye Drops
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:EyeDropsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 235800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 279700000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Juvederm Collection
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:JuvedermCollectionMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 656100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 614800000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Kybella And Belkyra
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 3300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 6300000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Linzess And Constella
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 23800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 24100000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Lumigan And Ganfort
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 360800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 392600000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Other
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 379500000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Other Products Revenues
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherProductsRevenuesMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 342600000 | USD | 20200218 | Abrir documento fuente |
International · Operating Segments · Ozurdex
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OzurdexMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 274600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 187700000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Rapaflo
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:RapafloMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 6000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 6400000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Restasis
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:RestasisMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 50200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 64500000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Skin Care
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:SkinCareMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 14600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 15200000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Tazorac
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:TazoracMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 700000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Teflaro
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:TeflaroMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 6000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 300000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Viberzi
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ViberziMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1300000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Viibryd Fetzima
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 11400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 7200000 | USD | 20190215 | Abrir documento fuente |
International · Operating Segments · Zenpep
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ZenpepMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 400000 | USD | 20190215 | Abrir documento fuente |
International · Aczone · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:AczoneMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 300000 | USD | 20181031 | Abrir documento fuente |
International · Alloderm · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:AllodermMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 2200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 3800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 1600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5500000 | USD | 20181031 | Abrir documento fuente |
International · Alphagan And Combigan · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 40900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 78500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 37600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 40500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 129300000 | USD | 20181031 | Abrir documento fuente |
International · Botox · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:BotoxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 274600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 515900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 241300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 256300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 777100000 | USD | 20181031 | Abrir documento fuente |
International · Breast Implants · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:BreastImplantsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | -31400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | -20200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 11200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 35600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 119600000 | USD | 20181031 | Abrir documento fuente |
International · Bystolic And Byvalson · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1600000 | USD | 20181031 | Abrir documento fuente |
International · Canasa And Salofalk · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 4100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 7700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 3600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 4400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 13100000 | USD | 20181031 | Abrir documento fuente |
International · Carafate And Sulcrate · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 1300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 2100000 | USD | 20181031 | Abrir documento fuente |
International · Coolsculpting Consumables · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 20300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 38100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 17800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 14200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 40800000 | USD | 20181031 | Abrir documento fuente |
International · Coolsculpting Systems And Add On Applicators · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 11600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 22200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 10600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 8300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 21800000 | USD | 20181031 | Abrir documento fuente |
International · Dalvance · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:DalvanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 2200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 2200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 1300000 | USD | 20181031 | Abrir documento fuente |
International · Delzicol And Asacol HD · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 9700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 20000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 10300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 10900000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 35000000 | USD | 20181031 | Abrir documento fuente |
International · Eye Drops · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:EyeDropsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 57300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 112700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 55400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 66800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 208000000 | USD | 20181031 | Abrir documento fuente |
International · Juvederm Collection · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:JuvedermCollectionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 172700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 330500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 157800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 138600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 440800000 | USD | 20181031 | Abrir documento fuente |
International · Kybella And Belkyra · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 2200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 1600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5300000 | USD | 20181031 | Abrir documento fuente |
International · Latisse · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:LatisseMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 2000000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 6300000 | USD | 20181031 | Abrir documento fuente |
International · Linzess And Constella · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 4800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 10300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 5500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 5700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 17700000 | USD | 20181031 | Abrir documento fuente |
International · Lumigan And Ganfort · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 90400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 175500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 85100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 94800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 295700000 | USD | 20181031 | Abrir documento fuente |
International · Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 85500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 167200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 81700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 94600000 Reexpresado | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 290500000 | USD | 20181031 | Abrir documento fuente |
International · Ozurdex · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:OzurdexMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 81000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 144100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 63100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 25800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 158100000 | USD | 20181031 | Abrir documento fuente |
International · Rapaflo · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:RapafloMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 1400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 2000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 4600000 | USD | 20181031 | Abrir documento fuente |
International · Restasis · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:RestasisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 11900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 22300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 10400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 13600000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 47900000 | USD | 20181031 | Abrir documento fuente |
International · Skin Care · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:SkinCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 3700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 6400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 2700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 3700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
International · Skin Medica · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:SkinMedicaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 1700000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 5300000 | USD | 20181031 | Abrir documento fuente |
International · Tazorac · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:TazoracMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 200000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 600000 | USD | 20181031 | Abrir documento fuente |
International · Teflaro · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:TeflaroMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 30 jun 2019 | 200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 200000 | USD | 20200507 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 600000 | USD | 20181031 | Abrir documento fuente |
International · Viberzi · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:ViberziMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 700000 | USD | 20181031 | Abrir documento fuente |
International · Viibryd Fetzima · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:InternationalMember;srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 2700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 4800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 2100000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 4900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Operating Segments
Statement Business Segments · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 5834900000 | USD | 20200218 | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 1455700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 1249900000 | USD | 20200507 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 5322900000 | USD | 20200218 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1381300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
US General Medicine · Operating Segments · Armour Thyroid
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ArmourThyroidMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 218500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 198800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Avycaz
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AvycazMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 116700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 94600000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Bystolic And Byvalson
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 600600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 583800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Canasa And Salofalk
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 31500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 169200000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Carafate And Sulcrate
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 212500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 217800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Dalvance
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:DalvanceMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 81900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 56100000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Delzicol And Asacol HD
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 76700000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 130800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Estrace Cream
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:EstraceCreamMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 49000000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Liletta
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LilettaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 79100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 50900000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Linzess And Constella
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 803200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 761100000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Lo Loestrin Fe
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LoLoestrinFeMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 588900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 527700000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Minastrin Fe
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:MinastrinFeMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 9500000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Namenda
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:NamendaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 22800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 71000000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Namzaric
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:NamzaricMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 88600000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 115800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Other
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 690800000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Other Products Revenues
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherProductsRevenuesMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 797600000 | USD | 20200218 | Abrir documento fuente |
US General Medicine · Operating Segments · Saphris
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:SaphrisMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 135300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 139700000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Savella
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:SavellaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 88500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 85000000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Teflaro
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:TeflaroMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 147000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 128000000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Viberzi
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ViberziMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 187900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 176500000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Viibryd Fetzima
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 412100000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 342400000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Vraylar
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:VraylarMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 857500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 487100000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Operating Segments · Zenpep
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:ZenpepMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 288000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 237300000 | USD | 20190215 | Abrir documento fuente |
US General Medicine · Armour Thyroid · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:ArmourThyroidMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 56700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 106700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 50000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 48000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 145400000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Avycaz · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:AvycazMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 26700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 56400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 29700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 24700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 70000000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Bystolic And Byvalson · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:BystolicAndByvalsonMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 150500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 278800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 128300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 151200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 432100000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Canasa And Salofalk · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:CanasaAndSalofalkMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 8000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 18200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 10200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 46800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 130400000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Carafate And Sulcrate · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:CarafateAndSulcrateMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 56200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 110500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 54300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 53400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 163700000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Dalvance · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:DalvanceMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 20300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 32300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 12000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 9200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 38800000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Delzicol And Asacol HD · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:DelzicolAndAsacolHDMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 31600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 56300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 24700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 32100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 102900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Estrace Cream · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:EstraceCreamMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 14800000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 34300000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Lexapro · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:LexaproMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 15600000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 44800000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Liletta · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:LilettaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 21900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 36700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 14800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 12700000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 36300000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Linzess And Constella · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:LinzessAndConstellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 196000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 357300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 161300000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 204800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 555900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Lo Loestrin Fe · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:LoLoestrinFeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 145500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 271300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 125800000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 141500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 383900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Minastrin Fe · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:MinastrinFeMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 600000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 6600000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Namenda · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:NamendaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 6100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 15600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 9500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 16300000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
US General Medicine · Namenda Xr · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:NamendaXrMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 jul 2018 – 30 sept 2018 | 16200000 | USD | 20181031 | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 60100000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Namzaric · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:NamzaricMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 22600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 46000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 23400000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 28000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 93200000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 197000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 387900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 190900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 185000000 Reexpresado | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 482700000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Saphris · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:SaphrisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 32600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 64500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 31900000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 36400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 102900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Savella · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:SavellaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 22300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 43000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 20700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 22400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 61400000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Teflaro · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:TeflaroMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 37000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 70500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 33500000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 33400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 98000000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Viberzi · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:ViberziMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 50800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 88000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 37200000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 46800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 127600000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Viibryd Fetzima · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:ViibrydFetzimaMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 107800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 192800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 85000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 88500000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 246900000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Vraylar · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:VraylarMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 196100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 339800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 143700000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 138000000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 336600000 | USD | 20181031 | Abrir documento fuente |
US General Medicine · Zenpep · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USGeneralMedicineMember;srt:ProductOrServiceAxis=agn:ZenpepMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 70000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 133000000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 63000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 62100000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 170500000 | USD | 20181031 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments
Statement Business Segments · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 6820000000 | USD | 20200218 | Abrir documento fuente |
| 1 abr 2019 – 30 jun 2019 | 1785100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 1542900000 | USD | 20200507 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 6920300000 | USD | 20200218 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 1706200000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Aczone
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AczoneMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 9300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 55100000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Alloderm
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AllodermMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 395900000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 407300000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Alphagan And Combigan
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 360000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 375400000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Botox
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BotoxMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 2730500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 2545800000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Breast Implants
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:BreastImplantsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 254400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 263000000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Coolsculpting Consumables
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 185300000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 235300000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Coolsculpting Systems And Add On Applicators
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 62800000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 126300000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Eye Drops
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:EyeDropsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 230400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 202700000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Juvederm Collection
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:JuvedermCollectionMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 587500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 548200000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Kybella And Belkyra
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 27400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 31800000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Lumigan And Ganfort
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 269200000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 291800000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Other
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 283500000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Other Products Revenues
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OtherProductsRevenuesMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 261900000 | USD | 20200218 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Ozurdex
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:OzurdexMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 125500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 111000000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Rapaflo
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:RapafloMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 23500000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 81900000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Restasis
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:RestasisMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 1138400000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 1197000000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Skin Care
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:SkinCareMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2019 – 31 dic 2019 | 158000000 | USD | 20200218 | Abrir documento fuente |
| 1 ene 2018 – 31 dic 2018 | 138800000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Operating Segments · Tazorac
Statement Business Segments · Consolidation Items · Product Or Service
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;srt:ProductOrServiceAxis=agn:TazoracMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 ene 2018 – 31 dic 2018 | 25400000 | USD | 20190215 | Abrir documento fuente |
US Specialized Therapeutics · Aczone · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:AczoneMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 1800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 3400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 1600000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 17400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 54500000 | USD | 20181031 | Abrir documento fuente |
US Specialized Therapeutics · Alloderm · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:AllodermMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 101200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 196200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 95000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 105800000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 312400000 | USD | 20181031 | Abrir documento fuente |
US Specialized Therapeutics · Alphagan And Combigan · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:AlphaganAndCombiganMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 91600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 174600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 83000000 | USD | 20200507 | Abrir documento fuente |
| 1 jul 2018 – 30 sept 2018 | 95400000 | USD | 5 nov 2019 · 22:00:24.000Z | Abrir documento fuente |
| 1 ene 2018 – 30 sept 2018 | 277700000 | USD | 20181031 | Abrir documento fuente |
US Specialized Therapeutics · Botox · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:BotoxMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 699400000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 1326500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 627100000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Breast Implants · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:BreastImplantsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 67600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 128800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 61200000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Coolsculpting Consumables · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:CoolsculptingConsumablesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 60700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 108500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 47800000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Coolsculpting Systems And Add On Applicators · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:CoolsculptingSystemsAndAddOnApplicatorsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 18200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 33300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 15100000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Eye Drops · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:EyeDropsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 57800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 107200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 49400000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Juvederm Collection · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:JuvedermCollectionMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 156600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 286300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 129700000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Kybella And Belkyra · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:KybellaAndBelkyraMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 8500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 15800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 7300000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Lumigan And Ganfort · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:LumiganAndGanfortMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 62100000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 119800000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 57700000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Other · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:OtherMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 71700000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 131200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 59500000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Ozurdex · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:OzurdexMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 29900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 60200000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 30300000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Rapaflo · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:RapafloMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 4500000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 16300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 11800000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Restasis · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:RestasisMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 310900000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 542600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 231700000 | USD | 20200507 | Abrir documento fuente |
US Specialized Therapeutics · Skin Care · Operating Segments
Statement Business Segments · Product Or Service · Consolidation Items
Dimensiones de origen
us-gaap:StatementBusinessSegmentsAxis=agn:USSpecializedTherapeuticsMember;srt:ProductOrServiceAxis=agn:SkinCareMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Periodo | Valor | Unidad | Presentado | Evidencia |
|---|---|---|---|---|
| 1 abr 2019 – 30 jun 2019 | 42600000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 30 jun 2019 | 77300000 | USD | 8 ago 2019 · 21:29:12.000Z | Abrir documento fuente |
| 1 ene 2019 – 31 mar 2019 | 34700000 | USD | 20200507 | Abrir documento fuente |